𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Studies on the metabolism and toxicological detection of the designer drug 2,5-dimethoxy-4-methyl-β- phenethylamine (2C-D) in rat urine using gas chromatographic/mass spectrometric techniques

✍ Scribed by Denis S. Theobald; Hans H. Maurer


Publisher
John Wiley and Sons
Year
2006
Tongue
English
Weight
376 KB
Volume
41
Category
Article
ISSN
1076-5174

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

The phenethylamine‐derived designer drug 2,5‐dimethoxy‐4‐methyl‐β‐phenethylamine (2C‐D) was found to be metabolized in rats by O‐demethylation at position 2 or 5 followed by N‐acetylation or by deamination with oxidation to the corresponding acids or reduction to the corresponding alcohol. Furthermore, 2C‐D was hydroxylated at the methyl group or deaminated followed by reduction to the corresponding alcohol or by oxidation to the corresponding acid. Most of the metabolites were excreted in conjugated form. The authors' systematic toxicological analysis (STA) procedure using full‐scan GC/MS allowed the detection of an intake of a dose of 2C‐D in rat urine that corresponds to a common drug user's dose. Assuming similar metabolism, the described STA procedure should be suitable for proof of an intake of 2C‐D in human urine. Copyright © 2006 John Wiley & Sons, Ltd.


📜 SIMILAR VOLUMES


New designer drug 4-iodo-2,5-dimethoxy-β
✍ Denis S. Theobald; Michael Pütz; Erhard Schneider; Hans H. Maurer 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 283 KB

## Abstract Studies are described on the metabolism and the toxicological analysis of the phenethylamine‐derived designer drug 4‐iodo‐2,5‐dimethoxy‐β‐phenethylamine (2C‐I) in rat urine using gas chromatographic/mass spectrometric (GC/MS) techniques, and for a particular question, using capillary el

Designer drug 2,4,5-trimethoxyamphetamin
✍ Andreas H. Ewald; Giselher Fritschi; Hans H. Maurer 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 249 KB

## Abstract Studies are described on the metabolism and the toxicological detection of the amphetamine‐derived designer drug 2,4,5‐trimethoxyamphetamine (TMA‐2) in rat urine using gas chromatographic/mass spectrometric (GC/MS) techniques. The identified metabolites indicated that TMA‐2 was metaboli

New designer drug 2,5-dimethoxy-4-ethylt
✍ Denis S. Theobald; Roland F. Staack; Michael Puetz; Hans H. Maurer 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 393 KB

## Abstract Studies are described on the metabolism and the toxicological analysis of the phenethylamine‐derived designer drug 2,5‐dimethoxy‐4‐ethylthio‐β‐phenethylamine (2C‐T‐2) in rat urine using gas chromatography/mass spectrometry (GC/MS) after enzymatic cleavage of conjugates, liquid‐liquid ex

New designer drug, 2,5-dimethoxy-4-propy
✍ Denis S. Theobald; Susanna Fehn; Hans H. Maurer 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 234 KB

## Abstract Studies are described on the metabolism and toxicological analysis of the phenethylamine‐derived designer drug 2,5‐dimethoxy‐4‐propylthio‐β‐phenethylamine (2C‐T‐7) in rat urine using gas chromatography/mass spectrometry (GC/MS). The identified metabolites indicated that 2C‐T‐7 was metab

Designer drugs 2,5-dimethoxy-4-bromo-amp
✍ Andreas H. Ewald; Giselher Fritschi; Wolf-Rainer Bork; Hans H. Maurer 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 237 KB

## Abstract Studies are described on the metabolism and the toxicological analysis of the amphetamine‐derived designer drug 2,5‐dimethoxy‐4‐bromo‐amphetamine (DOB) and its corresponding __N__‐methyl analogue 2,5‐dimethoxy‐4‐bromo‐methamphetamine (MDOB) in rat urine using gas chromatographic/mass sp

New designer drug α-pyrrolidinovalerophe
✍ Christoph Sauer; Frank T. Peters; Claudia Haas; Markus R. Meyer; Giselher Fritsc 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 227 KB

## Abstract The aim of the present study was to identify the metabolites of the new designer drug α‐pyrrolidinovalerophenone (PVP) in rat urine using GC/MS techniques. Eleven metabolites of PVP could be identified suggesting the following metabolic steps: hydroxylation of the side chain followed by